Proficio Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$870K Sell
1,955
-124
-6% -$55.2K 0.05% 171
2025
Q1
$1.01M Buy
2,079
+1,101
+113% +$534K 0.08% 129
2024
Q4
$394K Buy
978
+311
+47% +$125K 0.03% 226
2024
Q3
$310K Sell
667
-179
-21% -$83.2K 0.03% 213
2024
Q2
$397K Buy
846
+23
+3% +$10.8K 0.04% 198
2024
Q1
$344K Buy
823
+34
+4% +$14.2K 0.04% 222
2023
Q4
$321K Sell
789
-4
-0.5% -$1.63K 0.04% 213
2023
Q3
$276K Buy
793
+73
+10% +$25.4K 0.04% 231
2023
Q2
$253K Buy
720
+32
+5% +$11.3K 0.03% 243
2023
Q1
$217K Buy
+688
New +$217K 0.03% 265
2020
Q4
Sell
-757
Closed -$206K 197
2020
Q3
$206K Buy
757
+22
+3% +$5.99K 0.04% 163
2020
Q2
$213K Buy
+735
New +$213K 0.04% 157
2019
Q3
Sell
-333
Closed -$61K 1507
2019
Q2
$61K Buy
333
+14
+4% +$2.57K 0.02% 317
2019
Q1
$59K Buy
319
+66
+26% +$12.2K 0.02% 298
2018
Q4
$42K Sell
253
-5
-2% -$830 0.02% 341
2018
Q3
$50K Buy
258
+8
+3% +$1.55K 0.02% 353
2018
Q2
$42K Buy
250
+10
+4% +$1.68K 0.02% 401
2018
Q1
$39K Sell
240
-8
-3% -$1.3K 0.01% 416
2017
Q4
$37K Sell
248
-52
-17% -$7.76K 0.01% 422
2017
Q3
$46K Buy
300
+19
+7% +$2.91K 0.02% 399
2017
Q2
$44K Buy
281
+31
+12% +$4.85K 0.02% 410
2017
Q1
$29K Buy
250
+172
+221% +$20K 0.01% 520
2016
Q4
$6K Buy
78
+7
+10% +$538 ﹤0.01% 726
2016
Q3
$6K Buy
71
+13
+22% +$1.1K ﹤0.01% 689
2016
Q2
$6K Buy
58
+54
+1,350% +$5.59K ﹤0.01% 671
2016
Q1
$0 Sell
4
-41
-91% ﹤0.01% 1179
2015
Q4
$6K Buy
+45
New +$6K 0.01% 396